First up, Mark Zuckerberg and Priscilla Chan are shifting their philanthropic focus. The Meta CEO and physician announced they're zeroing in on biology and AI to accelerate disease cures. This marks a significant pivot from their previous emphasis on education and housing.

Next, the Chan Zuckerberg Initiative is consolidating its scientific efforts under a new name, Biohub, aiming to use AI to speed up research. They're also integrating EvolutionaryScale, a frontier AI research lab, into their operations. Alex Rives, co-founder of EvolutionaryScale, will lead the scientific charge, bringing along 50 employees to join Biohub.

Meanwhile, Chan and Zuckerberg gathered around 50 AI researchers and tech leaders, including Stripe CEO Patrick Collison, to discuss merging cutting-edge AI with biology. Zuckerberg emphasized the success of the Biohub model and their intent to expand on it.

Between the lines, Chan explained their broad approach, choosing not to focus on a specific disease. Instead, they aim to empower scientists to take risks and explore bold questions in biology. This mission aligns with Chan's personal journey, sparked by a childhood curiosity about science.

However, this shift hasn't been without its challenges. Communities benefiting from the Initiative's earlier projects, like a school in East Palo Alto offering free tuition and healthcare, are feeling the impact. The school is set to close after the 2025-26 school year.

Finally, while the goal of curing all diseases is ambitious, Zuckerberg and Chan believe it's achievable and worth pursuing.

First up, Mark Zuckerberg shared his thoughts on the ambitious goals of curing all diseases with AI. He highlighted a contrast between biologists, who see the task as wildly ambitious, and AI experts, who wonder why it should take decades. Zuckerberg believes the AI perspective is gradually prevailing.

Next, Microsoft is making strides in AI with its new "Humanist Superintelligence" initiative. AI chief Mustafa Suleyman explained that Microsoft aims to create AI systems focused on serving humanity, rather than just maximizing performance. This move is part of Microsoft's strategy to compete in the race for artificial general intelligence, alongside other tech giants like OpenAI and Google.

Meanwhile, OpenAI's CEO Sam Altman described AI's potential as both a powerful tool and a risky experiment. Speaking with Warriors coach Steve Kerr, Altman acknowledged AI's dual nature in curing diseases or posing new threats. However, he stopped short of advocating for stronger regulation, emphasizing the complexity of AI's evolution.

In other news, Palantir CEO Alex Karp criticized Wall Street analysts for not understanding the success of companies like his. He argued that analysts are stuck in outdated ways of thinking, missing the potential of AI-driven software that has rewarded Palantir's shareholders amid the tech boom.

Finally, for the Star Trek fans out there, Lego announced its first "Star Trek" set. A 3,600-piece USS Enterprise will be available on November 28th for $399.99.